The United Kingdom’s use of genomic sequencing to identify a more infectious strain of SARS-COV-2 has largely served as a wake-up call for inadequate use of the technology in the U.S.
MarketWatch.com - Top Stories, MarketWatch
Sun, 01/17/2021 - 1:13pm
The United Kingdom’s use of genomic sequencing to identify a more infectious strain of SARS-COV-2 has largely served as a wake-up call for inadequate use of the technology in the U.S.